Patterns of inflammation linked to ulcer disease

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 1, 2000, Pages 27-40

  Dixon, Michael F ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Acid production; Chronic gastritis; Duodenal ulcer; Duodenitis; Gastric ulcer; H. pylori

Indexed keywords

ANTIBIOTIC AGENT; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; DISEASE PREDISPOSITION; DUODENITIS; DUODENUM ULCER; ERADICATION THERAPY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; NONHUMAN; PEPTIC ULCER; REVIEW; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH MUCOSA LESION; STOMACH ULCER;

EID: 0034100854     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0057     Document Type: Article

References (77)

1. Cruveilhier J. Traite d'Anatomie Pathologique Generale. 1862;Bailliére, Paris.
2. Konjetzny G E. Zur chirurgischen Beureilung der chronischen Gastritis. Archiv für klinischen Chirurgie. 129:1924;139-171.
3. Hebbel R. Chronic gastritis: its relation to gastric and duodenal ulcer and to gastric cancer. American Journal of Pathology. 19:1943;43-71.
4. Magnus H A. The pathology of simple gastritis. Journal of Pathology and Bacteriology. 58:1946;431-439.
5. Schrager J, Spink R, Mitra S. The antrum in patients with duodenal and gastric ulcers. Gut. 8:1967;497-508.
6. Gear M WL, Truelove S C, Whitehead R. Gastric ulcer and gastritis. Gut. 12:1971;639-645.
7. Trier J S. Morphology of the gastric mucosa in patients with ulcer diseases. American Journal of Digestive Diseases. 21:1976;138-140.
8. Correa P. The epidemiology and pathogenesis of chronic gastritis. Three etiologic entities. Frontiers of Gastroenterological Research. 6:1980;98-108.
9. Correa P. Chronic gastritis: a clinico-pathological classification. American Journal of Gastroenterology. 83:1988;504-509.
10. Sobala G M, Axon A TR, Dixon M F. Morphology of chronic gastritis: relationship to age, Helicobacter pylori status and peptic ulceration. European Journal of Gastroenterology and Hepatology. 4:1992;825-829.
11. Meyer-Roseberg K, Scott D R, Melchers K, Sachs G. The effect of environmental pH on the protein motive force of H. pylori. Gastroenterology. 111:1996;886-900.
12. Scott D R, Weeks D, Hong C. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology. 114:1998;58-70.
13. Ferrero R L, Lee A. The importance of urease in acid protection for the gastric-colonising bacteria H. pylori and H. felis sp. nov. Microbiology, Ecology in Health and Disease. 4:1991;121-134.
14. Clyne M, Labigne A, Drumm B. H. pylori requires an acidic environment to survive in the presence of urea. Infection and Immunity. 63:1995;1669-1673.
15. Greig M A, Neithercut W D, Hossack M, McColl K EL. Harnessing of urease activity of H. pylori to induce self-destruction of the bacterium. Journal of Clinical Pathology. 44:1991;157-159.
16. Roland M, Berstad A, Liavag I. A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patients. Scandinavian Journal of Gastroenterology. 10:1975;181-186.
17. Stolte M, Meining A, Schmitz J M. Changes in Helicobacter pylori -induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 12:1998;247-253.
18. Moayyedi P, Morrow S, Peacock R. Changing patterns of H. pylori gastritis in long-standing acid suppression. Gastroenterology. 116:1999;A257.
19. Danon S J, O'Rourke J L, Moss N D, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology. 108:1995;1386-1395.
20. Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 96:1989;615-625.
21. Walker M M, Dixon M F. Gastric metaplasia: its role in duodenal ulceration. Alimentary Pharmacology and Therapeutics. 10:1996;119-128.
22. Tatsuta M, Ishii H, Yamamura H. Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. Gut. 30:1989;311-315.
23. Gaskin R J, Gad A, Barros A AJ. Natural history and morphology of secretagogue-induced ulcers in rats. Gastroenterology. 69:1975;903-910.
24. Rhodes J. Experimental production of gastric epithelium in the duodenum. Gut. 5:1964;454-458.
25. Florey H W, Jennings M A, Jennings D A. The reactions of the intestine of the pig to gastric juice. Journal of Pathology and Bacteriology. 49:1939;105-123.
26. Natelson B, Dubois A, Sodetz P J. Effect of multiple-stress procedures on monkey gastroduodenal mucosa, serum gastrin and hydrogen ion kinetics. Digestive Diseases and Sciences. 22:1977;888-897.
27. Kreuning J, van der Wal A M, Kuiper G, Lindeman J. Chronic nonspecific duodenitis: a multiple biopsy study of the duodenal bulb in health and disease. Scandinavian Journal of Gastroenterology. 24:1989;16-20.
28. Parrish J A, Rawlins D C. Intestinal mucosa in the Zollinger-Ellison syndrome. Gut. 6:1965;286-289.
29. Wyatt J I, Rathbone B J, Dixon M F. Campylobacter pyloridis and acid-induced gastric metaplasia in the pathogenesis of duodenitis. Journal of Clinical Pathology. 40:1987;841-848.
30. Marshall B J, McGeehie D B, Rogers P A, Glancy R J. Pyloric Campylobacter infection and gastroduodenal disease. Medical Journal of Australia. 142:1985;439-444.
31. Warren J R, Marshall B J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. i:1983;1273-1275.
32. Steer H W. Ultrastructure of cell migration through the gastric epithelium and its relationship to bacteria. Journal of Clinical Pathology. 28:1975;639-646.
33. Steer H W. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut. 25:1984;1203-1210.
34. Steer H W. The gastroduodenal epithelium in peptic ulceration. Journal of Pathology. 146:1985;355-359.
35. Walker M M, Logan R PH, Gummett P A. The influence of Helicobacter pylori eradication on the structure of duodenal ulcer scars. European Journal of Gastroenterology and Hepatology. 5:1993;S97-S98.
36. Yang H T, Dixon M F, Zuo J S. Helicobacter pylori infection and gastric metaplasia in China. Journal of Clinical Gastroenterology. 20:1995;110-112.
37. Crabtree J E, Shallcross T M, Wyatt J I. Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Digestive Diseases and Sciences. 36:1991;1266-1273.
38. Dixon M F, Sobala G M, Wyatt J I, Axon A TR. Gastric metaplasia and H. pylori associated gastritis as predictors of the duodenal ulcer diathesis. Irish Journal of Medical Science. 161:1992;11.
39. Sobala G M, Crabtree J E, Pentith J A. Screening dyspepsia by serology to Helicobacter pylori. Lancet. 338:1991;94-96.
40. Stolte M, Eidt S, Ohnsmann A. Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Zeitschrift für Gastroenterologie. 28:1990;229-233.
41. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. American Journal of Gastroenterology. 82:1987;192-199.
42. Graham D Y, Alpert L C, Smith J L, Yoshimura H H. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. American Journal of Gastroenterology. 83:1988;974-980.
43. Sobala G M, Crabtree J, Dixon M F. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology and gastric juice ascorbic acid concentrations. Gut. 32:1991;1415-1418.
44. Dixon M F. Acid, ulcers and H pylori. Lancet. 342:1993;384-385.
45. Sipponen P, Hyvärinen H, Siurala M. H. pylori corpus gastritis - relation to acid output. Journal of Physiology and Pharmacology. 47:1996;151-159.
46. Ruiz B, Correa P, Fontham E TH, Ramakrishnan T. Antral atrophy, Helicobacter pylori colonization and gastric pH. American Journal of Clinical Pathology. 105:1996;96-101.
47. Beales I L, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut. 42:1998;227-234.
48. Konturek P C, Ernst H, Konturek S J. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut. 40:1997;463-469.
49. Dixon M F. Helicobacter pylori and peptic ulceration: histopathological aspects. Journal of Gastroenterology and Hepatology. 6:1991;125-130.
50. Crabtree J E, Taylor J D, Wyatt J I. Mucosal IgA recognition of Helicobacter pylori 120kDa protein, peptic ulceration, and gastric pathology. Lancet. 338:1991;332-334.
51. Dixon M F, Sobala G M, Wyatt J I. Surface epithelial degeneration in H pylori gastritis: relationship to coexistent peptic ulcer. Irish Journal of Medical Science. 161:1992;13.
52. Stemmermann G N. Intestinal metaplasia of the stomach. Cancer. 74:1994;556-564.
53. Hanby A M, Poulsom R, Singh S. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology. 105:1993;1110-1116.
54. Terres A M, Pajares J M, O'Toole D. H pylori infection is associated with down-regulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. Journal of Clinical Pathology. 51:1998;410-412.
55. van Zanten S JOV, Dixon M F, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology. 116:1999;1217-1229.
56. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology. 63:1972;584-592.
57. Fujishima K, Misumi A, Akagi M. Histopathologic study on development and extension of atrophic changes in the gastric mucosa. Gastroenterologia Japonica. 19:1984;9-17.
58. Tatsuta M, Okuda S. Location, healing, and recurrence of gastric ulcers in relation to fundal gastritis. Gastroenterology. 69:1975;897-902.
59. Tytgat G NJ, Dixon M F. Helicobacter pylori infection: role in peptic ulcer disease. Northfield T C, Mendall M, Goggin P M. Helicobacter pylori Infection - Pathophysiology, Epidemiology and Management. 1993;75-87 Kluwer Academic, London.
60. Figura N, Guglielmetti P, Rossolini A. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. Journal of Clinical Microbiology. 27:1989;225-226.
61. Cover T L, Cao P, Lind C D. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infection and Immunity. 61:1993;5008-5012.
62. Phadnis S H, Ilver D, Janzon L. Pathological significance and molecular characterisation of the vacuolating toxin gene of Helicobacter pylori. Infection and Immunity. 62:1994;1557-1565.
63. Cover T L, Tummuru M KR, Cao P. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. Journal of Biological Chemistry. 269:1994;10566-10573.
64. Atherton J C, Cao P, Peek R M. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Journal of Biological Chemistry. 270:1995;17771-17777.
65. Cover T L, Dooley C O, Blaser M J. Characterisation of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infection and Immunity. 58:1990;603-610.
66. Tummuru M KR, Cover T L, Blaser M J. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infection and Immunity. 61:1993;1799-1809.
67. Censini S, Lange C, Xiang Z. Cag A pathogenicity island (PAI) of Helicobacter pylori encodes for type I-specific virulence factors. Gut. 39:1996;A72.
68. Crabtree J E, Farmery S M, Lindley I JD. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. Journal of Clinical Pathology. 47:1994;945-950.
69. +Helicobacter pylori strains. Journal of Clinical Microbiology. 33:1995;1496-1500.
70. Ching C K, Wong B C, Kwok E. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. American Journal of Gastroenterology. 91:1996;949-953.
71. Crabtree J E, Wyatt J I, Sobala G M. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut. 34:1993;1339-1343.
72. Parsonnet J, Friedman G D, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 40:1997;297-301.
73. Warburton V J, Everett S, Mapstone N P. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. Journal of Clinical Pathology. 51:1998;55-61.
74. Atherton J C, Tham K T, Peek R M. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. Journal of Infectious Disease. 174:1996;552-556.
75. Hamlet A, Thoreson A C, Nilsson O. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology. 116:1999;259-268.
76. McColl K EL, El-Omar E, Gillen D. H. pylori -induced hypergastrinaemia is related to bacterial CagA status. Gut. 40:1997;A46.
77. Dixon M F, Genta R M, Yardley J H, Correa P. Classification and grading of gastritis: the updated Sydney System. American Journal of Surgical Pathology. 20:1996;1161-1181.